Advisory Letters
The U.S. FDA issued letters to these companies for illegally marketing products for the treatment or prevention of serious diseases. Thirty days after FDA issued these letters, the companies listed have failed to voluntarily cease illegally marketing products for serious diseases.
Registrar and Registry Abuse Complaints
The U.S. FDA sent abuse complaints to registrars managing websites that offer any unapproved drugs or uncleared devices, or potentially counterfeit, controlled, adulterated or misbranded products to U.S. consumers in violation of U.S. law.
Fraudulent Coronavirus Disease 2019 (COVID-19) Products
The U.S. Food and Drug Administration is issuing warning letters to firms for selling fraudulent products with claims to prevent, treat, mitigate, diagnose or cure coronavirus disease 2019 (COVID-19).
Health Fraud Recalls
The page provides information gathered from press announcements and other public notices about certain recalls of health fraud related products regulated by FDA.
